These cells were immunoreactive to the common leukocyte IHC marker CD45 (Figure 2C) and the T-cell marker CD3 (Figure 2D), while negative for the macrophage marker CD68 (Figure 2E) and were considered tumor-associated lymphocytes (TILs). The gene discussed is CD68; the disease is neoplasm.